Analgesic tolerance to microinjection of the μ-opioid agonist DAMGO into the ventrolateral periaqueductal gray

Neuropharmacology

Volumn 52, Issue 8, 2007, Pages 1580-1585

  Meyer, Paul J ^a   Fossum, Erin N ^a   Ingram, Susan L ^a   Morgan, Michael M ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Adaptation; Analgesia; Antinociception; Opiate tolerance; Opioid receptor; Periaqueductal gray

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MORPHINE SULFATE; MU OPIATE RECEPTOR AGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG MECHANISM; DRUG POTENTIATION; DRUG TOLERANCE; LOW DRUG DOSE; MALE; MICROINJECTION; MORPHINE TOLERANCE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; THALAMUS VENTRAL NUCLEUS;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG TOLERANCE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; MALE; MICROINJECTIONS; MORPHINE; PAIN MEASUREMENT; PERIAQUEDUCTAL GRAY; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME;

EID: 34249696508     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.03.002     Document Type: Article

References (43)

1. Alvarez V.A., Arttamangkul S., Dang V., Salem A., Whistler J.L., Von Zastrow M., Grandy D.K., and Williams J.T. mu-Opioid receptors: ligand-dependent activation of potassium conductance, desensitization, and internalization. J. Neurosci. 22 (2002) 5769-5776
2. Chieng B., and Christie M.D. Local opioid withdrawal in rat single periaqueductal gray neurons in vitro. J. Neurosci. 16 (1996) 7128-7136
3. Dang V.C., and Williams J.T. Morphine-induced mu-opioid receptor desensitization. Mol. Pharmacol. 68 (2005) 1127-1132
4. Duttaroy A., Kirtman R., Farrell F., Phillips M., Philippe J., Monderson T., and Yoburn B.C. The effect of cumulative dosing on the analgesic potency of morphine in mice. Pharmacol. Biochem. Behav. 58 (1997) 67-71
5. Duttaroy A., and Yoburn B.C. The effect of intrinsic efficacy on opioid tolerance. Anesthesiology 82 (1995) 1226-1236
6. Fairbanks C.A., and Wilcox G.L. Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine. J. Pharmacol. Exp. Ther. 288 (1999) 1107-1116
7. Fang F.G., Haws C.M., Drasner K., Williamson A., and Fields H.L. Opioid peptides (DAGO-enkephalin, dynorphin A(1-13), BAM 22P) microinjected into the rat brainstem: comparison of their antinociceptive effect and their effect on neuronal firing in the rostral ventromedial medulla. Brain Res. 501 (1989) 116-128
8. He L., Fong J., von Zastrow M., and Whistler J.L. Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 108 (2002) 271-282
9. He L., and Whistler J.L. An opiate cocktail that reduces morphine tolerance and dependence. Curr. Biol. 15 (2005) 1028-1033
10. Ingram S.L., Vaughan C.W., Bagley E.E., Connor M., and Christie M.J. Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. J. Neurosci. 18 (1998) 10269-10276
11. Jacquet Y.F., and Lajtha A. Paradoxical effects after microinjection of morphine in the periaqueductal gray matter in the rat. Science 185 (1974) 1055-1057
12. Kalant H., LeBlanc A.E., and Gibbins R.J. Tolerance to, and dependence on, some non-opiate psychotropic drugs. Pharmacol. Rev. 23 (1971) 135-191
13. Kieffer B.L., and Evans C.J. Opioid tolerance-in search of the holy grail. Cell 108 (2002) 587-590
14. Kolesnikov Y.A., Jain S., Wilson R., and Pasternak G.W. Peripheral morphine analgesia: synergy with central sites and a target of morphine tolerance. J. Pharmacol. Exp. Ther. 279 (1996) 502-506
15. Lane D.A., Patel P.A., and Morgan M.M. Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats. Neuroscience 135 (2005) 227-234
16. Ling G.S., Paul D., Simantov R., and Pasternak G.W. Differential development of acute tolerance to analgesia, respiratory depression, gastrointestinal transit and hormone release in a morphine infusion model. Life Sci. 45 (1989) 1627-1636
17. Ling G.S., Simantov R., Clark J.A., and Pasternak G.W. Naloxonazine actions in vivo. Eur. J. Pharmacol. 129 (1986) 33-38
18. Ling G.S., Spiegel K., Nishimura S.L., and Pasternak G.W. Dissociation of morphine's analgesic and respiratory depressant actions. Eur. J. Pharmacol. 86 (1983) 487-488
19. Mattia A., Vanderah T., Mosberg H.I., and Porreca F. Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 258 (1991) 583-587
20. Morgan M.M., Clayton C.C., and Lane D.A. Behavioral evidence linking opioid-sensitive GABAergic neurons in the ventrolateral periaqueductal gray to morphine tolerance. Neuroscience 118 (2003) 227-232
21. Morgan M.M., Fossum E.N., Levine C.S., and Ingram S.L. Antinociceptive tolerance revealed by cumulative intracranial microinjections of morphine into the periaqueductal gray in the rat. Pharmacol. Biochem. Behav. 85 (2006) 214-219
22. Morgan M.M., Fossum E.N., Stalding B.M., and King M.M. Morphine antinociceptive potency on chemical, mechanical, and thermal nociceptive tests in the rat. J. Pain 7 (2006) 358-366
23. Morgan M.M., Tierney B.W., and Ingram S.L. Intermittent dosing prolongs tolerance to the antinociceptive effect of morphine microinjection into the periaqueductal gray. Brain Res. 1059 (2005) 173-178
24. Moskowitz A.S., and Goodman R.R. Autoradiographic analysis of mu1, mu2, and delta opioid binding in the central nervous system of C57BL/6BY and CXBK (opioid receptor-deficient) mice. Brain Res. 360 (1985) 108-116
25. Paronis C.A., and Holtzman S.G. Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats. J. Pharmacol. Exp. Ther. 262 (1992) 1-9
26. Pasternak G.W. Insights into mu opioid pharmacology the role of mu opioid receptor subtypes. Life Sci. 68 (2001) 2213-2219
27. Paul D., Bodnar R.J., Gistrak M.A., and Pasternak G.W. Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice. Eur. J. Pharmacol. 168 (1989) 307-314
28. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (2005), Elsevier Academic Press, Amsterdam
29. Pick C.G., Paul D., and Pasternak G.W. Comparison of naloxonazine and beta-funaltrexamine antagonism of mu 1 and mu 2 opioid actions. Life Sci. 48 (1991) 2005-2011
30. Porreca F., Heyman J.S., Mosberg H.I., Omnaas J.R., and Vaught J.L. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse. J. Pharmacol. Exp. Ther. 241 (1987) 393-400
31. Roerig S.C., Fujimoto J.M., Franklin R.B., and Lange D.G. Unidirectional non-cross-tolerance (UNCT) in rats and an apparent dissociation between narcotic tolerance and physical dependence. Brain Res. 327 (1985) 91-96
32. Rossi G.C., Pasternak G.W., and Bodnar R.J. Synergistic brainstem interactions for morphine analgesia. Brain Res. 624 (1993) 171-180
33. Siuciak J.A., and Advokat C. The synergistic effect of concurrent spinal and supraspinal opiate agonisms is reduced by both nociceptive and morphine pretreatment. Pharmacol. Biochem. Behav. 34 (1989) 265-273
34. Sosnowski M., and Yaksh T.L. Differential cross-tolerance between intrathecal morphine and sufentanil in the rat. Anesthesiology 73 (1990) 1141-1147
35. Stafford K., Gomes A.B., Shen J., and Yoburn B.C. mu-Opioid receptor downregulation contributes to opioid tolerance in vivo. Pharmacol. Biochem. Behav. 69 (2001) 233-237
36. Stevens C.W., and Yaksh T.L. Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion. J. Pharmacol. Exp. Ther. 250 (1989) 1-8
37. Tallarida R.J. Drug Synergism and Dose Effect Data Analysis (2000), Chapman & Hall/CRC, Boca Raton
38. Tiano M.J., Walker E.A., and Dykstra L.A. Cross-tolerance to etorphine differentiates mu-opioid agonists in a rat tail withdrawal assay. Analgesia 3 (1998) 221-257
39. Tortorici V., Robbins C.S., and Morgan M.M. Tolerance to the antinociceptive effect of morphine microinjections into the ventral but not lateral-dorsal periaqueductal gray of the rat. Behav. Neurosci. 113 (1999) 833-839
40. Tseng L.F., Lin J.J., and Collins K.A. Partial antinociceptive cross-tolerance to intracerebroventricular beta-endorphin in mice tolerant to systemic morphine. Eur. J. Pharmacol. 241 (1993) 63-70
41. Walker E.A., and Young A.M. Differential tolerance to antinociceptive effects of mu opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats. Psychopharmacology 154 (2001) 131-142
42. Wenger G.R. Cumulative dose-response curves in behavioral pharmacology. Pharmacol. Biochem. Behav. 13 (1980) 647-651
43. Whistler J.L., Chuang H.H., Chu P., Jan L.Y., and von Zastrow M. Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 23 (1999) 737-746